MAPT and Alzheimer disease: The concentrations of Aβ42 and Tau proteins (total Tau and its phosphorylated form Tau181) in the cerebrospinal fluid (CSF) are considered the major CSF biomarkers in AD pathogenesis, and they have been included as research criteria for the diagnosis of AD since 2007 [161].